Skip to content

Ivermectin prophylaxis for Covid-19 Infection in Health care Personnel

Efficacy and Safety of Ivermectin prophylaxis for Covid-19 Infection in Health care Personnel: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031665
Enrollment
50
Registered
2021-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ivermectin Tablets : Ivermetin-200 mcg / kg two doses - 72 hours apart [ 40-60 kg : 12 mg
60 -80 kg :18 mg
80 kg : 24 mg] Control Intervention1: Vit C: Vitamin C 1000mg Once daily for 14 days

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Health care personnel (HCP) >18 years age 2. HCP identified as primary contact and have High Risk defined as per ICMR guidelines for contracting COVID-19 infection 3. HCP who have not presented with general symptoms such as general discomfort, fever, cough, dyspnoea or muscle pain in the last week. 4. HCP who are willing to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Already infected with SARS-cov-2/ previous COVID-19 within the last 6 months 2. HCW who have taken any medication as possible prophylaxis for COVID-19 3. Pregnancy 4. Prior enrolment into this or other COVID-19 prevention or treatment trials. 5. HCW with known allergy to ivermectin

Design outcomes

Primary

MeasureTime frame
RT- Polymerase chain reaction (PCR) confirmed SARS-CoV-2 infection [ Day 10]- As per State covid management guidelinesTimepoint: Day 10

Secondary

MeasureTime frame
Development of Symptoms ( Fever ,Cough, Sore Throat, Myalgia, Diarrhea, Shortness of Breath) [ within 14 days after enrolment ]Timepoint: 14 day

Countries

India

Contacts

Public ContactDr Manisha Bisht

AIIMS Rishikesh

manishabisht@yahoo.co.in8475000263

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026